|
WO2021027729A1
|
|
Immunomodulator
|
|
WO2021027721A1
|
|
Immunomodulator
|
|
WO2021027722A1
|
|
Immunomodulator
|
|
WO2021027724A1
|
|
Immunomodulator
|
|
WO2020259689A1
|
|
Method for identifying complex biological system by means of recognizable mixture
|
|
WO2020216298A1
|
|
Hdac inhibitor, preparation method therefor and use thereof
|
|
WO2020156363A1
|
|
Immunomodulator
|
|
WO2020151682A1
|
|
Macrocyclic immunomodulator
|
|
WO2020108415A1
|
|
Intermediate compound of trk kinase inhibitor compound and preparation method
|
|
CN110872615A
|
|
High-throughput next-generation sequencing method for sequencing nucleotide double strands
|
|
WO2020001560A1
|
|
Reaction monitoring method in synthetic dna coding compound
|
|
WO2019223718A1
|
|
Immunomodulator
|
|
KR20210018223A
|
|
Macrocycle kinase inhibitors
|
|
WO2019149198A1
|
|
Dna-encoded compound library and compound screening method
|
|
WO2019134705A1
|
|
Immunomodulator
|
|
WO2019134707A1
|
|
Immunomodulator
|
|
WO2019120267A1
|
|
Imidazo[1,2-b]pyridazine macrocyclic kinase inhibitor
|
|
KR20190113879A
|
|
Code library synthesis method and composition
|
|
EP3284851A1
|
|
Method for solid-phase synthesis of dna-encoded chemical library
|
